ResMed (WBO:RMD) Total Stockholders Equity : €4,260 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is ResMed Total Stockholders Equity?

ResMed's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €4,260 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. ResMed's Book Value per Share for the quarter that ended in Mar. 2024 was €29.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. ResMed's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.25.

ResMed Total Stockholders Equity Historical Data

The historical data trend for ResMed's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Total Stockholders Equity Chart

ResMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

1,833.89

2,217.36

2,395.11

3,179.27

3,811.90

ResMed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															3,672.96	3,811.90	3,982.60	4,109.86	4,259.53

ResMed (WBO:RMD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

ResMed's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4259.526	-	0)	/	146.887
	=	29.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

ResMed's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(31.358	+	1042.691)	/	4259.526
	=	0.25

ResMed Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ResMed's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (WBO:RMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (WBO:RMD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany R1MD34:Brazil RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.